
Kantipur Pharmaceuticals Lab Limited is opening its Initial Public Offering (IPO) for Nepalis working abroad from Mangsir 10.
The company is issuing 90,000 shares worth Rs. 90 lakh at a face value of Rs. 100 per share. The shares represent 10% of the total shares allocated for the general public and are reserved for Nepalis working abroad.
Eligible applicants can apply for a minimum of 10 shares and a maximum of 7,000 shares.
The IPO will remain open until Mangsir 15. If the issue is not fully subscribed within this period, the deadline will be extended until Mangsir 24.
Muktinath Capital Limited has been appointed as the issue and sales manager. Nepalis working abroad can apply through C-ASBA member banks and financial institutions or through the Mero Share online platform. Applicants must have valid labor approval issued by the concerned government authority.
Kantipur Pharmaceuticals Lab Limited (KPLL) has launched its IPO in the Manufacturing sector, seeking to raise Rs. 9,000,000. The offering consists of 90,000 units priced at Rs. 100.00 per unit, with Muktinath Capital Limited serving as the issue manager.
The subscription period, which is open to Foreign Workers, is scheduled from November 26, 2026 to December 01, 2026, with a minimum application requirement of 10 units.





Note: This result link is hosted on the official website of the issue manager and provides the same allotment data published by CDSC.
For faster access during high traffic periods, it is recommended to use the CDSC IPO result portal or the issue manager’s official website.